Having established that Ptpn2 gene knockout sensitizes melanoma cells to IFNγ treatment, we next asked whether the small-molecule Ptpn2 inhibitors (PTP 1 through PTP 10) could have the same effect. The gene discussed is IFNG; the disease is melanoma.